Publisher Correction: Cytoplasmic FBXO38 mediates PD-1 degradation

被引：0
|
作者：
Xiwei Liu [1 ]
Xiangbo Meng [2 ]
Zuomiao Lin [3 ]
Shutan Jiang [1 ]
Haifeng Liu [1 ]
Shao-cong Sun [4 ]
Xiaolong Liu [1 ]
Penghui Zhou [5 ]
Xiaowu Huang [6 ]
Lai Wei [7 ]
Wei Yang [8 ]
Chenqi Xu [9 ]
机构：
[1] Chinese Academy of Sciences,CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology
[2] Shandong University,Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine
[3] University of Chinese Academy of Sciences,School of Life Science, Hangzhou Institute for Advanced Study
[4] Chinese Institutes for Medical Research,Institute of Immunology
[5] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[6] Fudan University,Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital
[7] Ministry of Education,Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University)
[8] Fudan University,Shanghai Key Laboratory of Organ Transplantation, Zhongshan Hospital
[9] Guangzhou Medical University,Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, The Second Affiliated Hospital
[10] Southern Medical University,Guangdong Provincial Key Laboratory of Molecular Oncologic Pathology, Department of Pathology, School of Basic Medical Sciences
[11] Southern Medical University,Department of Pathology, Nanfang Hospital
来源：
EMBO Reports | 2024年 / 25卷 / 12期
关键词：
D O I：
10.1038/s44319-024-00298-0
中图分类号：
学科分类号：
摘要：
[graphic not available: see fulltext]
引用
收藏
页码：5838 / 5838
相关论文
共 50 条
  • [1] Cytoplasmic FBXO38 mediates PD-1 degradation
    Liu, Xiwei
    Meng, Xiangbo
    Lin, Zuomiao
    Jiang, Shutan
    Liu, Haifeng
    Sun, Shao-cong
    Liu, Xiaolong
    Zhou, Penghui
    Huang, Xiaowu
    Wei, Lai
    Yang, Wei
    Xu, Chenqi
    EMBO REPORTS, 2024, 25 (10) : 4168 - 4171
  • [2] Cytoplasmic FBXO38 mediates PD-1 degradation ( vol 25 , pg 4168 , 2024)
    Liu, Xiwei
    Meng, Xiangbo
    Lin, Zuomiao
    Jiang, Shutan
    Liu, Haifeng
    Sun, Shao-cong
    Liu, Xiaolong
    Zhou, Penghui
    Huang, Xiaowu
    Wei, Lai
    Yang, Wei
    Xu, Chenqi
    EMBO REPORTS, 2024, 25 (12) : 5838 - 5838
  • [3] FBXO38 Drives PD-1 to Destruction
    Serman, Taryn M.
    Gack, Michaela U.
    TRENDS IN IMMUNOLOGY, 2019, 40 (02) : 81 - 83
  • [4] FBXO38 is dispensable for PD-1 regulation
    Dibus, Nikol
    Salyova, Eva
    Kolarova, Karolina
    Abdirov, Alikhan
    Pagano, Michele
    Stepanek, Ondrej
    Cermak, Lukas
    EMBO REPORTS, 2024, 25 (10) : 4206 - 4225
  • [5] FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
    Meng, Xiangbo
    Liu, Xiwei
    Guo, Xingdong
    Jiang, Shutan
    Chen, Tingting
    Hu, Zhiqiang
    Liu, Haifeng
    Bai, Yibing
    Xue, Manman
    Hu, Ronggui
    Sun, Shao-cong
    Liu, Xiaolong
    Zhou, Penghui
    Huang, Xiaowu
    Wei, Lai
    Yang, Wei
    Xu, Chenqi
    NATURE, 2018, 564 (7734) : 130 - +
  • [6] FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
    Xiangbo Meng
    Xiwei Liu
    Xingdong Guo
    Shutan Jiang
    Tingting Chen
    Zhiqiang Hu
    Haifeng Liu
    Yibing Bai
    Manman Xue
    Ronggui Hu
    Shao-cong Sun
    Xiaolong Liu
    Penghui Zhou
    Xiaowu Huang
    Lai Wei
    Wei Yang
    Chenqi Xu
    Nature, 2018, 564 : 130 - 135
  • [7] THE E3 LIGASE FBXO38 CONTROLS PD-1 EXPRESSION AND ANTITUMOR IMMUNITY
    不详
    CANCER DISCOVERY, 2019, 9 (02) : 162 - 162
  • [8] FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation
    Tian, Tongguan
    Xie, Xiao
    Yi, Wanwan
    Zhou, Yuefan
    Xu, Yixin
    Wang, Zhenxiang
    Zhang, Junjing
    Lin, Mingen
    Zhang, Ruonan
    Lv, Zhongwei
    Li, Xinxing
    Lv, Lei
    Xu, Yanping
    CELL REPORTS, 2023, 42 (11):
  • [9] Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
    Gabriel Abril-Rodriguez
    Davis Y. Torrejon
    Wei Liu
    Jesse M. Zaretsky
    Theodore S. Nowicki
    Jennifer Tsoi
    Cristina Puig-Saus
    Ignacio Baselga-Carretero
    Egmidio Medina
    Michael J. Quist
    Alejandro J. Garcia
    William Senapedis
    Erkan Baloglu
    Anusha Kalbasi
    Gardenia Cheung-Lau
    Beata Berent-Maoz
    Begoña Comin-Anduix
    Siwen Hu-Lieskovan
    Cun-Yu Wang
    Catherine S. Grasso
    Antoni Ribas
    Nature Cancer, 2020, 1 : 264 - 264
  • [10] FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS-STING pathway activation
    Wu, Yijia
    Lin, Yao
    Shen, Feiyang
    Huang, Rui
    Zhang, Zhe
    Zhou, Min
    Fang, Yan
    Shen, Jianfeng
    Fan, Xianqun
    NEOPLASIA, 2024, 49
12345